Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids

Killian T, Buntz A, Herlet T, et al.

Nucleic Acids Research 2019, vol: 47(10) doi: 10.1093/nar/gkz137

Abstract

We report a novel system for efficient and specific targeted delivery of large nucleic acids to and into cells. Plasmid DNA and core histones were assembled to chromatin by salt gradient dialysis and subsequently connected to bispecific antibody derivatives (bsAbs) via a nucleic acid binding peptide bridge. The resulting reconstituted vehicles termed ‘plasmid-chromatin’ deliver packaged nucleic acids to and into cells expressing antigens that are recognized by the bsAb, enabling intracellular functionality without detectable cytotoxicity. High efficiency of intracellular nucleic acid delivery is revealed by intracellular expression of plasmid encoded genes in most (∼90%) target cells to which the vehicles were applied under normal growth/medium conditions in nanomolar concentrations. Specific targeting, uptake and transgene expression depends on antibody-mediated cell surface binding: plasmid chromatin of identical composition but with non-targeting bsAbs or without bsAbs is ineffective. Examples that demonstrate applicability, specificity and efficacy of antibody-targeted plasmid chromatin include reporter gene constructs as well as plasmids that enable CRISPR/Cas9 mediated genome editing of target cells.

View Publication
 

Topics: Gene Therapy, Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

 

Previous Article
Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing
Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing

Up next
Intrinsic differential scanning fluorimetry for fast and easy identification of Adeno-Associated Virus serotypes
Intrinsic differential scanning fluorimetry for fast and easy identification of Adeno-Associated Virus serotypes

Want to see more
gene therapy content?

Explore resources